Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

PD-L1 Antikörper (AA 19-328)

PD-L1 Reaktivität: Human FACS, ELISA Wirt: Kaninchen Monoclonal DM123 unconjugated
Produktnummer ABIN7272794
  • Target Alle PD-L1 Antikörper anzeigen
    PD-L1 (CD274 (PD-L1))
    Bindungsspezifität
    • 29
    • 16
    • 15
    • 12
    • 11
    • 9
    • 8
    • 7
    • 5
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 19-328
    Reaktivität
    • 164
    • 107
    • 63
    • 7
    • 6
    • 5
    • 5
    • 1
    • 1
    Human
    Wirt
    • 125
    • 58
    • 17
    • 4
    • 2
    • 1
    Kaninchen
    Klonalität
    • 108
    • 97
    • 2
    Monoklonal
    Konjugat
    • 92
    • 15
    • 13
    • 11
    • 9
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    Dieser PD-L1 Antikörper ist unkonjugiert
    Applikation
    • 136
    • 101
    • 56
    • 40
    • 38
    • 28
    • 17
    • 16
    • 14
    • 14
    • 10
    • 7
    • 5
    • 5
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Flow Cytometry (FACS), ELISA
    Aufreinigung
    Purified from cell culture supernatant by affinity chromatography
    Immunogen
    Recombinant human PD-L1 (Phe19-Arg328) (ABIN6961165) produced by using human HEK293 cells
    Klon
    DM123
    Isotyp
    IgG
    Top Product
    Discover our top product PD-L1 Primärantikörper
  • Applikationshinweise
    ELISA 1/5000-10000,Flow Cyt  1/100
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Reconstitute with deionized water
    Buffer
    Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.,0.1 % Procline 300
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
    Haltbarkeit
    12 months
  • Target
    PD-L1 (CD274 (PD-L1))
    Andere Bezeichnung
    PD-L1 (PD-L1 Produkte)
    Synonyme
    B7-H antikoerper, B7H1 antikoerper, PD-L1 antikoerper, PDCD1L1 antikoerper, PDCD1LG1 antikoerper, PDL1 antikoerper, A530045L16Rik antikoerper, B7h1 antikoerper, Pdcd1l1 antikoerper, Pdcd1lg1 antikoerper, Pdl1 antikoerper, RGD1566211 antikoerper, CD274 molecule antikoerper, CD274 antigen antikoerper, programmed cell death 1 ligand 2 antikoerper, CD274 antikoerper, Cd274 antikoerper, PDCD1LG2 antikoerper
    Hintergrund
    Synonyms:PD-L1, CD274, B7-H1, PDCD1L1, PDCD1LG1
    Description:This gene encodes an immune inhibitory receptor ligand that is expressed by hematopoietic and non-hematopoietic cells, such as T cells and B cells and various types of tumor cells. The encoded protein is a type I transmembrane protein that has immunoglobulin V-like and C-like domains. Interaction of this ligand with its receptor inhibits T-cell activation and cytokine production. During infection or inflammation of normal tissue, this interaction is important for preventing autoimmunity by maintaining homeostasis of the immune response. In tumor microenvironments, this interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human malignancies, including colon cancer and renal cell carcinoma. Alternative splicing results in multiple transcript variants.
    Molekulargewicht
    26 kDa
    Gen-ID
    29126
    UniProt
    Q9NZQ7
    Pathways
    Cancer Immune Checkpoints
Sie sind hier: